DHG Pharmaceutical JSC Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
986,599.00
904,484.00
1,159,174.00
1,099,613.00
864,751.00
821,023.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
312,631.00
478,383.00
-703,204.00
-43,045.00
-294,579.00
114,133.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
1,333,595.00
1,474,369.00
420,040.00
1,020,007.00
554,821.00
958,965.00
Cash Flow from Investing Activities
691,103.00
-602,736.00
-359,688.00
-472,451.00
-58,090.00
-380,883.00
Cash Flow from Financing Activities
-1,957,374.00
-902,846.00
-170.00
-550,279.00
-527,864.00
-575,379.00
Net Cash Inflow / Outflow
67,038.00
-31,276.00
60,116.00
-2,945.00
-31,088.00
2,726.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-286.00
-62.00
-65.00
-222.00
45.00
23.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in VND Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of DHG Pharmaceutical JSC
Figures in Million
consolidated Cash Flow Results
Change(VND)
Change(%)
Profit Before Tax
986599.267177
446247.738093
5,40,352.00
121.09%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
312631.701888
-378113.779785
6,90,744.00
182.68%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
1333595.579639
73441.552898
12,60,154.00
1715.86%
Cash Flow from Investing Activities
691103.374718
-95854.054491
7,86,957.00
821.00%
Cash Flow from Financing Activities
-1957374.626414
49653.073103
-20,07,027.00
-4042.10%
Net Cash Inflow / Outflow
67038.117384
27209.909578
39,829.00
146.37%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-286.210559
-30.661932
-256.00
-833.44%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is -9.55% vs 251.01% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
13,33,595.58
14,74,369.20
-9.55%






